We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies. Close

FDA biological drug database a ‘boon’ for patients

Intellectual Property Magazine

FDA biological drug database a ‘boon’ for patients

US biosimilar associations have ‘applauded’ the FederalDrug Administration (FDA) for updating its ‘Purple Book’ database.

The rest of this document is only available to i-law.com online subscribers.

If you are already a subscriber, please enter your details below to log in.

Enter your email address to log in as a user on your corporate account.
Remember me on this computer

Not yet an i-law subscriber?


Request a trial Find out more